A Study of Trastuzumab Deruxtecan (T-DXd) and Cetuximab in People With Colorectal Cancer

NCT07691489 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer
Adenocarcinoma of the Colon
Adenocarcinoma of the Rectum

Interventions

DRUG: Fam-Trastuzumab Deruxtecan-Nxki

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]
[object Object]
[object Object]